278 related articles for article (PubMed ID: 14690607)
21. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.
Chang CC; Ye BH; Chaganti RS; Dalla-Favera R
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6947-52. PubMed ID: 8692924
[TBL] [Abstract][Full Text] [Related]
22. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
23. Backbone resonance assignment of the BCL6-BTB/POZ domain.
Lin LY; Evans SE; Fairall L; Schwabe JWR; Wagner SD; Muskett FW
Biomol NMR Assign; 2018 Apr; 12(1):47-50. PubMed ID: 28929458
[TBL] [Abstract][Full Text] [Related]
24. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
Baron BW; Anastasi J; Thirman MJ; Furukawa Y; Fears S; Kim DC; Simone F; Birkenbach M; Montag A; Sadhu A; Zeleznik-Le N; McKeithan TW
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2860-5. PubMed ID: 11854457
[TBL] [Abstract][Full Text] [Related]
25. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
[TBL] [Abstract][Full Text] [Related]
26. A new functional domain of Bcl6 family that recruits histone deacetylases.
Zhang H; Okada S; Hatano M; Okabe S; Tokuhisa T
Biochim Biophys Acta; 2001 Sep; 1540(3):188-200. PubMed ID: 11583814
[TBL] [Abstract][Full Text] [Related]
27. Bcl6-dependent transcriptional repression by BAZF.
Takenaga M; Hatano M; Takamori M; Yamashita Y; Okada S; Kuroda Y; Tokuhisa T
Biochem Biophys Res Commun; 2003 Apr; 303(2):600-8. PubMed ID: 12659862
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.
Xu HE; Stanley TB; Montana VG; Lambert MH; Shearer BG; Cobb JE; McKee DD; Galardi CM; Plunket KD; Nolte RT; Parks DJ; Moore JT; Kliewer SA; Willson TM; Stimmel JB
Nature; 2002 Feb; 415(6873):813-7. PubMed ID: 11845213
[TBL] [Abstract][Full Text] [Related]
29. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
Li H; Leo C; Schroen DJ; Chen JD
Mol Endocrinol; 1997 Dec; 11(13):2025-37. PubMed ID: 9415406
[TBL] [Abstract][Full Text] [Related]
30. The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70.
Muscat GE; Burke LJ; Downes M
Nucleic Acids Res; 1998 Jun; 26(12):2899-907. PubMed ID: 9611234
[TBL] [Abstract][Full Text] [Related]
31. Structural basis of Apt48 inhibition of the BCL6 BTB domain.
Zacharchenko T; Kalverda AP; Wright SC
Structure; 2022 Mar; 30(3):396-407.e3. PubMed ID: 34774129
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional repression by the proto-oncogene BCL-6.
Seyfert VL; Allman D; He Y; Staudt LM
Oncogene; 1996 Jun; 12(11):2331-42. PubMed ID: 8649773
[TBL] [Abstract][Full Text] [Related]
33. Interactions that determine the assembly of a retinoid X receptor/corepressor complex.
Ghosh JC; Yang X; Zhang A; Lambert MH; Li H; Xu HE; Chen JD
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5842-7. PubMed ID: 11972046
[TBL] [Abstract][Full Text] [Related]
34. Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1.
Yang SH; Vickers E; Brehm A; Kouzarides T; Sharrocks AD
Mol Cell Biol; 2001 Apr; 21(8):2802-14. PubMed ID: 11283259
[TBL] [Abstract][Full Text] [Related]
35. Multiple domains participate in distance-independent LAZ3/BCL6-mediated transcriptional repression.
Albagli O; Dhordain P; Bernardin F; Quief S; Kerkaert JP; Leprince D
Biochem Biophys Res Commun; 1996 Mar; 220(3):911-5. PubMed ID: 8607866
[TBL] [Abstract][Full Text] [Related]
36. Structure of the POZ domain of human LRF, a master regulator of oncogenesis.
Schubot FD; Tropea JE; Waugh DS
Biochem Biophys Res Commun; 2006 Dec; 351(1):1-6. PubMed ID: 17052694
[TBL] [Abstract][Full Text] [Related]
37. MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein.
Xia ZB; Anderson M; Diaz MO; Zeleznik-Le NJ
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8342-7. PubMed ID: 12829790
[TBL] [Abstract][Full Text] [Related]
38. Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells.
Racanicchi S; Maccherani C; Liberatore C; Billi M; Gelmetti V; Panigada M; Rizzo G; Nervi C; Grignani F
EMBO J; 2005 Mar; 24(6):1232-42. PubMed ID: 15729358
[TBL] [Abstract][Full Text] [Related]
39. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2.
Han A; He J; Wu Y; Liu JO; Chen L
J Mol Biol; 2005 Jan; 345(1):91-102. PubMed ID: 15567413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
